Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/01/2026 ,inter alia, to consider and approve the Un-audited Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare Ltd has informed BSE that a meeting of its Resolution Plan Implementation Committee (RPIC) is scheduled for January 14, 2026. The committee will consider and approve the unaudited consolidated financial results of the company for the quarter and half year ended September 30, 2025, along with the limited review report from statutory auditors M/s. SSRC A & Co. The meeting is being chaired by Roshen Chordiya, the Erstwhile Resolution Professional of the company, indicating that Cian Healthcare is currently operating under a post-insolvency resolution framework. This appears to be the company's first set of consolidated results being filed after emerging from the Corporate Insolvency Resolution Process (CIRP). The company is an ISO 9001:2015 and WHO GMP certified pharmaceutical manufacturer based in Pune with operations in Uttarakhand.
This is only an advance intimation — no financial numbers are disclosed yet. For shareholders, the actual results on January 14 will be the key trigger, as they will offer the first meaningful look at the company's financial health after its insolvency resolution. The post-CIRP status is a material risk factor to keep in mind.